The safety of cancer vaccines is a key concern in their development and deployment. Extensive clinical trials are conducted to assess their safety profiles. Generally, preventive vaccines have been shown to have a favorable safety profile. Therapeutic vaccines, which are often administered to patients with compromised health, require more careful monitoring. The balance between efficacy and potential toxicity is a critical consideration in their use.
